10/26/2026
✨ GLP-1 medications are changing lives—and the conversation goes beyond the scale.
❤️ Heart health: Wegovy has been shown to reduce the risk of heart attack, stroke, and cardiovascular death in adults with established heart disease and overweight or obesity.
🔥 Inflammation: Clinical trials show semaglutide can lower CRP, a blood marker of inflammation.
🧠 Brain health: Research continues, but GLP-1s are not proven to prevent Alzheimer’s. Two large semaglutide trials did not slow its progression.
💉 What about microdosing? It’s getting attention, but we cannot assume very low doses deliver the same benefits seen with studied treatment doses. Microdosing is not an established treatment for inflammation, heart disease, or Alzheimer’s.
At Watts Wellness, we start with your health history, goals, and an individualized medical evaluation—
We do an in body scan on every patient before they start treating alongside nutrition, strength training, and ongoing support. 💙
Curious whether GLP-1 treatment fits your health needs? Schedule a consultation at WattsWellness.net.
StGeorgeUtah